Skip to main content
Explore URMC
menu

Majed A. Refaai, M.D.

Contact Information

Phone Numbers

Office: (585) 276-3927

Fax: (585) 273-3003

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting

Pathology

Biography

Dr. Refaai's clinical service is in Transfusion Medicine with subspecialty involvement in laboratory coagulation/thrombosis testing.

Research

Dr. Refaai's recent studies have included: The in-vitro effect of ABO anti-bodies on platelet function; The correlation between cancer and tissue factor (TF) plasma concentrations and its role in developing DVT; The relationship between the circulating TF and the cancer tissue concentrations of TF in different types of mouse models; Beriplex phase IIIb drug study for bleeding patients with Warfarin overdose; Beriplex phase IIIb drug study for surgical patients who require a quick reversal of Warfarin; The effect of ABO non-identical blood products transfusion on platelet function (in-vivo); Platelet transfusion in patients with positive heparin-induced thrombocytopenia; Comparison of tissue factor pathway inhibitor (TFPI) concentration and activity in mononuclear cells from normal individuals versus patients with Paroxysmal Nocturnal Hemoglobinuria; Comparison of TFPI concentrations in normal mouse plasma and endothelial cells versus a diabetic mouse model; Analysis of fatty acid ethyl ester (FAEE) concentrations in binge drinking, chronic alcoholics, and postmortem biopsies.

Credentials

Specialties

    Education

    1993
    MD | Aleppo University (Syria)

    Post-doctoral Training & Residency

    07/01/2006 - 06/30/2007
    Fellowship in Blood Banking/Transfusion Medicine at University of Texas Southwestern Medical Center

    06/30/2003 - 06/30/2006
    Residency in Pathology at Washington University in St. Louis

    04/01/1997 - 05/31/2003
    Fellowship at Massachusetts General Hospital

    04/01/1997 - 05/31/2003
    Fellowship in Pathology at Massachusetts General Hospital

    VIEW ALL expand_more

    Patents

    Patent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients
    Patent #: 3265116
    Issue Date: Jun 02, 2021
    Country: Europe
    Invented By: Majed A Refaai

    Patent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients
    Patent #: FR3265116
    Issue Date: Jun 02, 2021
    Country: France
    Invented By: Majed A Refaai

    Patent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients
    Patent #: DE3265116
    Issue Date: Jun 02, 2021
    Country: Germany
    Invented By: Majed A Refaai

    Patent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients
    Patent #: GB3265116
    Issue Date: Jun 02, 2021
    Country: United Kingdom
    Invented By: Majed A Refaai

    Patent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients
    Patent #: ZL 201680012653.9
    Issue Date: Mar 19, 2021
    Country: China, People's Republic of
    Invented By: Majed A Refaai

    Patent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients
    Patent #: 10,722,608
    Issue Date: Jul 28, 2020
    Country: United States
    Invented By: Majed A Refaai

    VIEW ALL expand_more

    Publications

    Journal Articles

    3/5/2023
    Gupta GK, Henrichs K, Nilsson K, Wagner S, Brown B, Masel D, Gestring ML, Vella MA, Refaai MA, Blumberg N. "Reduction of anti-A and anti-B isoagglutinin titers of group O whole blood units employing an ABO antibody immune adsorption column." Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.. 2023 Mar 5; :103686. Epub 2023 Mar 05.

    1/2023
    Spector H, McRae HL, Love T, Northam K, Refaai K, Rollins-Raval MA, Refaai MA. "Reduced Time to Procedure for Gastrointestinal Bleeding After Warfarin Reversal With Four-Factor Complex Concentrate as Compared to Plasma." Journal of clinical medicine research.. 2023 Jan; 15(1):51-57. Epub 2023 Jan 24.

    12/27/2022
    Hood C, Goldstein JN, Milling TJ, Refaai MA, Bajcic P, Goldstein B, Sarode R. "INR and vitamin K-dependent factor levels after vitamin K antagonist reversal with 4F-PCC or plasma." Blood advances.. 2022 Dec 27; Epub 2022 Dec 27.

    VIEW ALL PUBLICATIONS